Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Type 1 Diabetes Interventions: Other: Intensive lifestyle modification (hypocaloric Mediterranean diet and promotion of physical activity); Dietary Supplement: Butyrate; Dietary Supplement: Intensive lifestyle modification + butyrate Sponsors: Fundación...

Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Trisomy 8 Mosaicism; Trisomy 8 Associated Autoinflammatory Disease; Mucosal Ulcerations Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting Conditions: Trisomy 8 Mosaicism; Trisomy 8 Associated Autoinflammatory Disease;...

Extended Post-operative Oral TXA in Primary THA

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Osteoarthritis (OA) of the Hip; Osteoarthritis (OA) of the Knee Interventions: Drug: Extended oral tranexamic acid regimen; Drug: Placebo Sponsors: Oregon Health and Science University Not yet recruiting Conditions: Osteoarthritis (OA) of the Hip;...

A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Vitiligo Interventions: Drug: MH004 1.0% Ointment; Drug: MH004 Placebo Ointment Sponsors: Minghui Pharmaceutical (Hangzhou) Ltd Not yet recruiting Conditions: Vitiligo Interventions: Drug: MH004 1.0% Ointment; Drug: MH004 Placebo Ointment Sponsors:...

Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Autoimmune Encephalitis (AE); Autoimmune Cerebellitis Interventions: Drug: Blinatumomab Sponsors: Beijing Tiantan Hospital Not yet recruiting Conditions: Autoimmune Encephalitis (AE); Autoimmune Cerebellitis Interventions: Drug: Blinatumomab Sponsors:...

NOV-ERA – A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn’s Disease

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Fibrostenotic Crohn’s Disease Interventions: Drug: Ontunisertib; Drug: Ontunisertib; Drug: Ontunisertib; Drug: Placebo Sponsors: Agomab Spain S.L.U. Not yet recruiting Conditions: Fibrostenotic Crohn’s Disease Interventions: Drug:...